Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Once again, our agenda is modest. We hope to catch up on our reading, escort Mrs. Pharmalot to a highbrow cultural establishment and take several naps. And what about you? Spring is nearly here so this may be a good time to start cleaning your castle. You could reach out to someone special. Or you could prepare for your next important meeting by making stuff up (after all, if you-know-who-can-do-it…) Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon….

Pfizer (PFE) boosted compensation for chief executive officer Ian Read last year to $27.9 million, a 61 percent increase, Bloomberg News tells us. His pay included an $8 million special equity award that will vest if the drug maker’s average stock return tops 25 percent for 30 consecutive trading days before the end of 2022, according to a regulatory filing. Read, who turns 65 in May, also must remain CEO through at least next March and not work for a competitor for a minimum of two years after that to be eligible.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.